What is the sentiment of this news? Please choose an answer from {strong negative/moderately negative/mildly negative/neutral/mildly positive/moderately positive/strong positive}.

Amgen Q4 2022 revenue was up 3% y/y. Cancer therapy Lumakras is a new revenue driver.
moderately positive